I'm Scared My MG Is Getting Worse — What Does the Future Look Like?

by Dr. Jonas Witt
Medical Doctor
August 10, 2026
8 minutes
Get Personalized Health Support in 2 Minutes
Answer 9 quick questions to build an AI assistant tailored to your condition, backed by trusted medical knowledge and real experiences from people like you.
+40.000 People
have already shared their stories
Table of Contents

A difficult week with myasthenia gravis (MG) can make the future feel frightening. More double vision, trouble chewing, a weaker voice, heavier legs, or needing much more rest than usual can raise an immediate question: Is my MG permanently getting worse?

Often, the answer is not that simple.

MG can fluctuate. Symptoms may improve for a period and then become more noticeable again. A difficult stretch can reflect a flare, an infection, tiredness, a medicine change, or treatment that has not yet reached its full effect. It does not automatically mean MG will continue getting worse.

At the same time, changes involving breathing or swallowing deserve particular attention because they can become urgent.

TL;DR

  • A bad week does not automatically mean MG is permanently progressing. MG commonly has periods of improvement and worsening.
  • The first few years can be especially uncertain. This is often when the longer-term pattern of MG and response to treatment become clearer.
  • Long-term control is possible for many people. Some reach long periods with minimal symptoms, while others continue to experience flares or persistent weakness.
  • Severe or rapidly worsening breathing or swallowing problems are emergency warning signs. NHS guidance advises calling 999 for worsening severe breathing or swallowing difficulties.
  • Treatment options continue to evolve. Current UK guidance includes established treatments alongside newer options for selected forms of generalised MG.

Does feeling worse mean my MG is progressing?

No. Feeling worse does not necessarily mean MG is permanently progressing.

MG is known for fluctuating muscle weakness. Symptoms can be stronger at certain times of day, after activity, during illness, or when you are particularly tired. The NHS describes MG as a long-term condition that typically has phases when symptoms improve and phases when they become worse.

Several different situations can therefore feel like “progression.”

A flare or exacerbation

A flare is a period when existing MG symptoms become more troublesome. Infection, tiredness, stress, certain medicines, and other factors can contribute.

The important distinction is that a flare describes increased symptoms now. It does not by itself tell you what your MG will look like months or years later.

If you are trying to understand whether a change fits your usual MG pattern, our guide to how MG symptoms can change over time explains common eye, facial, swallowing, limb, and breathing symptoms.

Changes during the earlier course of MG

MG can change during the first few years after symptoms begin. Someone who initially has weakness affecting the eyes may later develop weakness elsewhere, although this does not happen to everyone.

If MG has remained limited to the eyes for two years or longer, the NHS notes that later spread to other muscle groups becomes unusual.

You can read more about what ocular MG can look like over time.

Treatment that needs time

Some medicines used to control the immune response in MG do not work immediately.

Traditional steroid-sparing medicines such as azathioprine and mycophenolate can take months before their benefits become noticeable. That waiting period can be frustrating, particularly when symptoms continue to fluctuate.

A change in symptoms during this period does not necessarily mean the treatment will ultimately be ineffective.

Our overview of medicines used in MG care explains the different roles of pyridostigmine, corticosteroids, immunosuppressive medicines, and other approaches.

A treatment change

Symptoms can sometimes change around adjustments to corticosteroids or other medicines. Treatment changes therefore need to be planned with the prescribing clinical team rather than interpreted in isolation.

Certain medicines used for other health conditions can also worsen MG symptoms in some circumstances. This is why it is useful to make every prescriber, dentist, pharmacist, and surgical team aware that you have MG.

See our guide to medicines that may need extra consideration with MG.

MG that remains difficult to control

Sometimes symptoms continue despite several appropriate treatments. Clinicians may describe this as uncontrolled or treatment-refractory MG.

That does not mean there are no further options. The treatment landscape has changed considerably, and UK guidance now considers several approaches depending on MG subtype, antibody status, previous treatment, symptoms, and individual circumstances.

What does the long-term future with MG usually look like?

The long-term course varies, but MG is not usually a condition that simply worsens in a straight line.

The NHS describes periods of increased symptoms followed by periods when symptoms improve. Permanent remission can occur, although it is not common.

For most people, MG does not significantly reduce life expectancy. Severe MG can still become life-threatening, particularly when breathing is affected, which is why recognising urgent symptoms remains important.

Research following generalised MG over several years also shows that meaningful improvement is possible. Contemporary long-term data suggest that many people eventually reach minimal manifestations or better, although a smaller group continues to experience persistent symptoms, exacerbations, or treatment side effects.

You can explore this topic further in our guide to MG and long-term life expectancy.

Why can the early years feel especially frightening?

The earlier phase of MG often contains the most uncertainty because symptoms, treatment response, and the longer-term pattern are still becoming clearer.

That uncertainty can make every difficult day feel significant.

Older long-term studies found that MG commonly reached its greatest severity during the first several years after onset. More recent research also suggests that how MG responds during the first two years can provide useful information about its longer-term course.

None of this allows anyone to predict exactly what will happen to an individual.

It does help explain why the beginning can feel particularly unstable. You may still be learning what fatigue feels like for you, which symptoms respond to rest, how medication timing affects your day, and what deserves urgent attention.

What do people living with MG describe in the mama health app?

Experiences shared through the mama health app often show that adapting to MG is as much about understanding changing patterns as it is about individual symptoms.

Several themes repeatedly appear in what people describe.

One is the uncertainty of the early period. A new symptom can feel like evidence that everything is deteriorating, especially before someone knows what their usual fluctuations look like.

Another is learning to pace differently. People describe planning demanding activities around times when they generally have more strength, allowing recovery time, and recognising that pushing through weakness can make the rest of the day harder.

There is also a recurring distinction between having a bad period and having a bad future. Some describe months or years with relatively stable symptoms interrupted by more difficult periods. Others describe needing several treatment adjustments before life becomes more predictable.

Fear after a severe swallowing episode, A&E visit, or breathing scare can also last longer than the physical episode itself. Over time, knowing personal warning signs and having clear instructions from a care team can make those situations feel less unknown.

Work, relationships, parenting, exercise, social plans, and everyday routines may need to change rather than disappear. Some people describe doing less on certain days, planning more carefully, or becoming more selective about where they spend their energy.

These shared experiences cannot predict another person's disease course. They can, however, help put unfamiliar feelings into words and provide useful questions to discuss with a doctor or MG specialist.

mama health organises user-shared experiences for reflection alongside information from trusted medical sources. It does not determine whether symptoms are worsening or recommend medical treatment.

Can you have good years and bad years with MG?

Yes. The fluctuating nature of MG means longer periods of stability can be interrupted by flares or periods of increased weakness.

An infection is one possible trigger. Tiredness, stress, medication changes, and certain medicines can also contribute to symptom worsening.

This variability is one reason a single difficult week should not be treated as a forecast of the next year.

Looking at the pattern over time can be more useful when speaking with your clinical team: what changed, which muscles were affected, how quickly the change happened, whether there was an infection or medicine change, and whether symptoms improved with rest.

Which MG symptoms need urgent attention?

Worsening severe breathing or swallowing difficulties require emergency medical attention.

NHS guidance advises calling 999 if you develop worsening severe breathing or swallowing difficulties because these symptoms can occur during a myasthenic crisis.

Warning signs can include:

  • severe or rapidly increasing shortness of breath
  • increasing difficulty swallowing
  • being unable to swallow normally
  • choking on saliva, food, or drink
  • a noticeably weaker cough
  • rapidly worsening weakness affecting the jaw or tongue
  • speech becoming much quieter, more nasal, or increasingly difficult
  • rapidly increasing weakness alongside an infection

A myasthenic crisis involves severe weakness affecting breathing and requires urgent assessment and treatment in hospital.

Swallowing changes can be particularly difficult to interpret when they develop gradually. Our guide to swallowing difficulties with MG explains how bulbar weakness can affect eating, drinking, and speech.

If you are unsure what should count as an emergency in your own situation, consider asking your MG specialist for a clear written plan before you need it.

Does having a myasthenic crisis mean MG will keep getting worse?

No. A myasthenic crisis is a serious event, but it does not by itself establish the future course of MG.

A crisis requires urgent hospital treatment because breathing muscles, swallowing muscles, or both can become severely weak.

Research suggests crises occur more often earlier in the disease course. Infection, changes in immune treatment, certain medicines, surgery, and other stresses can contribute.

Recovery after a crisis varies. The important point is that an emergency episode and long-term progression are not the same thing.

Emotionally, however, a crisis can change how safe everyday symptoms feel. Some people describe becoming much more alert to every change in breathing, swallowing, or speech afterward.

If fear about MG is becoming difficult to switch off even when symptoms are stable, our article on the emotional impact of living with MG explores this side of the condition.

What treatment options could change the future of MG?

MG treatment has several layers, and the appropriate approach depends on symptoms, MG subtype, antibody status, previous treatments, and other individual factors.

Established approaches can include pyridostigmine, corticosteroids, steroid-sparing immunosuppressive medicines, intravenous immunoglobulin (IVIg), plasma exchange, rituximab, and thymectomy in selected circumstances.

The 2025 Association of British Neurologists guideline placed greater emphasis on early thymectomy and described evidence supporting earlier use of rituximab in some forms of generalised MG.

Thymectomy has strong long-term evidence in appropriately selected AChR-positive generalised MG without thymoma. Follow-up from the randomised MGTX study found benefits lasting five years, including lower MG severity and reduced corticosteroid requirements compared with corticosteroids alone.

You can learn more about the relationship between the thymus and MG.

The UK pathway is also changing as newer targeted medicines are assessed.

In May 2026, NICE recommended rozanolixizumab as an add-on option for some adults in England with antibody-positive generalised MG that remains uncontrolled after previous treatment and meets specific additional criteria.

This does not mean that a particular medicine is appropriate simply because MG feels worse. Eligibility depends on clinical details that need to be reviewed by the treating specialist.

When is it worth discussing the treatment plan again?

A noticeable or sustained change in MG is a reasonable reason to revisit the treatment plan with your neurology team.

Questions can be particularly useful when:

  • symptoms are interfering with everyday activities more than before
  • weakness has changed noticeably from your usual pattern
  • you are experiencing repeated exacerbations
  • reducing corticosteroids repeatedly coincides with increased symptoms
  • current medicines are causing difficult side effects
  • you have needed repeated IVIg or plasma exchange
  • swallowing, speech, or breathing symptoms have become more frequent
  • you are unsure whether your current treatment has had enough time to work

The goal of that discussion is not to decide for yourself which medicine should come next. It is to understand what your current pattern could mean and which options your clinical team considers relevant.

What could I ask my MG specialist?

Specific questions can make an appointment more useful when fear and uncertainty make it difficult to know where to start.

You could ask:

  • “Could this be a flare rather than a long-term change in my MG?”
  • “Is my current treatment expected to have reached its full effect yet?”
  • “Could another medicine or a recent infection be contributing?”
  • “Which changes in swallowing or breathing should mean I call 999?”
  • “What should I do if these symptoms become worse outside clinic hours?”
  • “Would thymectomy still be relevant to my type of MG?”
  • “Could rituximab be relevant in my situation?”
  • “If my generalised MG remains uncontrolled, are newer targeted treatments relevant to my antibody status and previous treatment?”
  • “Could we write down a plan for what to do during a significant flare?”

You may also find it useful to bring brief notes about when symptoms changed, what was happening around that time, and which activities became more difficult. This can give your clinical team a clearer picture of your experience without requiring you to remember everything during the appointment.

What if the fear itself is becoming overwhelming?

Fear about the future can become a significant burden even when MG is physically stable.

Unpredictability is difficult. When strength can vary from one day to another, it is easy to interpret every change as evidence of what comes next.

People using the mama health app describe gradually becoming more familiar with their own patterns. For some, that means noticing that a difficult afternoon often improves after rest. For others, it means knowing exactly which swallowing or breathing changes deserve urgent help rather than trying to judge them while frightened.

It can also mean accepting that adaptation is not the same as giving up. Planning rest, asking for workplace adjustments, changing how activities are organised, or protecting time for recovery are ways of working with the reality of MG.

If anxiety about your health is affecting sleep, relationships, work, or everyday life, consider discussing that with a healthcare professional as well. Emotional support can be part of living with a long-term condition.

So, what does the future with MG look like?

For many people, the future is more variable and more manageable than the phrase “getting worse” suggests.

MG can have difficult periods. Some forms become more extensive early on. Some remain hard to control. Serious breathing or swallowing weakness can require emergency care.

But MG usually does not follow a simple downward path.

Symptoms can improve. Treatment can be adjusted. Long periods of stability are possible. Some people reach minimal symptoms or remission, while others build a workable life around ongoing limitations and occasional flares.

One of the clearest themes in experiences shared through the mama health app is that familiarity changes the emotional weight of MG. The condition may remain unpredictable, but people often become better able to describe what is happening, recognise their usual patterns, prepare questions, and know when something feels genuinely different.

A frightening week tells you how things feel right now. It does not, by itself, tell you what the rest of your life with MG will look like.

This content is informational and not a medical device.

mama health offers information and support and does not replace a doctor.

Get Personalized Health Support in 2 Minutes
Answer 9 quick questions to build an AI assistant tailored to your condition, backed by trusted medical knowledge and real experiences from people like you.
+40.000 People
have already shared their stories

Sources

  • Association of British Neurologists. Autoimmune myasthenia gravis management guidelines, 2025 update. Practical Neurology, 2025.
  • NHS. Myasthenia gravis: overview, symptoms, treatment and outlook.
  • NICE. Rozanolixizumab for antibody-positive generalised myasthenia gravis, Technology Appraisal TA1155, May 2026.
  • NHS England. Rituximab biosimilar commissioning policy for myasthenia gravis in adults, updated June 2026.
  • MGTX extension study. Five-year follow-up of thymectomy plus prednisone compared with prednisone alone in generalised non-thymomatous MG. The Lancet Neurology, 2019.
  • European Journal of Neurology. Long-term study of persistent symptoms, exacerbations, treatment effects and MG outcomes, 2024.
  • University Hospitals Sussex NHS Foundation Trust. Current information on the longer-term outlook for MG, reviewed April 2026.